-
Article
Telomere length and mortality in lean MAFLD: the other face of metabolic adaptation
Healthy weight (lean) patients with metabolic dysfunction-associated fatty liver disease (MAFLD) have a more favorable metabolic and histological profile in cross-sectional studies compared with their non-lean...
-
Article
MAFLD identifies patients with significant hepatic fibrosis better than MASLD
Diagnostic criteria for metabolic dysfunction-associated steatotic liver disease (MASLD) have been proposed but not yet validated. This study aimed to compare the diagnostic accuracy of the MASLD definition wi...
-
Article
MAFLD and chronic kidney disease: two sides of the same coin?
-
Article
Open AccessA metabolic associated fatty liver disease risk variant in MBOAT7 regulates toll like receptor induced outcomes
The breakdown of toll-like receptor (TLR) tolerance results in tissue damage, and hyperactivation of the TLRs and subsequent inflammatory consequences have been implicated as risk factors for more severe forms...
-
Article
Metabolically healthy obese and MAFLD: does weight status alone matter?
-
Article
Open AccessOne-shot preparation of topologically chimeric nanofibers via a gradient supramolecular copolymerization
Supramolecular polymers have emerged in the last decade as highly accessible polymeric nanomaterials. An important step toward finely designed nanomaterials with versatile functions, such as those of natural p...
